You will be redirected back to your article in seconds

Indie Newcomer A24 Hopes to Find Love for Low-Budget Slate

It was a stunt, but an amusing one. Tinder users at SXSW last month found themselves caught up in a dialogue with a hot 25-year-old named Ava, directing romantic questions to her Instagram page. Ava turned out to be a robot featured in “Ex Machina,” an indie sci-fi thriller that opened last week to a fine per-screen average of about $60,000 at four theaters.

With the major studios mounting giant marketing fusillades behind their summer tentpoles, it’s easy to conclude that there’s no room in the marketplace for indie pictures. Hence an initiative like the “Ex Machina” caper inspires optimism.

The film is distributed by A24, a 3-year-old company founded by three young (mid-30s) entrepreneurs, Daniel Katz, David Fenkel and John Hodges. A24 is among several new players exploring fresh marketing and dealmaking ideas in support of independent projects. It has found success with films like “The Spectacular Now” and “Spring Breakers,” and two current releases, “Ex Machina” and Noah Baumbach’s “While We’re Young,” show promise.

It also has run into the predictable indie road hazards — films that have instantly disappeared.

Overall, the reviews of A24 inside the business are mixed-to-good; its partners admit to their relative inexperience. They toss around words like “artsploitation” or “asymmetrical marketing.” But they are also careful. When they make festival bids, it is often in partnership with other entities — they acquired “The Witch” at Sundance in concert with DirecTV. “Slow West,” a British Western starring Michael Fassbender that was taken by the same two partners, will be available on DirecTV on April 16 and in theaters and on demand May 15.

All this is in keeping with a well-crafted survival scenario. A24 has negotiated a multiyear SVOD pact with Amazon, has a TV series on USA (“Playing House,” already picked up for a second season), and is prepping a series for NBC. The partners say they’re not in a rush, and admit they have “a lot to figure out.” Overall, A24 has acquired more than 25 movies, released 18, and hopes to distribute about 20 a year.

Is there room for all that in the indie field? “The guys have big ambitions and damn good taste,” says one producer who is weighing whether to commit his film to them. Reflecting this assessment, A24 has commanded commitments from directors like Baumbach and James Ponsoldt (“Spectacular Now”) as well as stars like Scarlett Johansson (“Under the Skin”) and Jake Gyllenhaal (“Enemy”). “Who else would come out with a documentary about Amy Winehouse in summer?” asks one admiring studio executive.

To improve productivity, the company has
started to develop its own films, and wants to become an increasingly aggressive buyer at festivals. At the most recent Sundance Fest, it bought three films — Ponsoldt’s “The End of the Tour,” Ryan Reynolds starrer “Mississippi Grind” and “The Witch” — for a reported total of about $6 million. It’s eager to make an impact at Cannes, and will have a (yet-to-be-announced) film showing in the market.

All things considered, the three partners — Fenkel, Katz and John Hodges — still have to figure out why their strategy for films like “The Rover” and “A Most Violent Year” failed to resonate with viewers. They are quick to point out that they have limited financial exposure on their flops, but still must prove that they can come up with that occasional big winner, one that will pull in foreign co-financiers.

Personally, I’m not ready to link up with Ava. But I hope she will help propel box office action for “Ex Machina,” which deserves to find an audience, like many films on this brash young indie’s slate.

More Voices

  • FX Confronts Streaming Thanks to Disney

    Kicking and Screaming, FX Is Forced to Confront Future in the Stream (Column)

    During his network’s presentation at the winter Television Critics Assn. press tour, FX chief John Landgraf made waves — and headlines — by mounting perhaps his most direct criticism yet of Netflix. Landgraf, whose briefings to the press tend to rely heavily on data about the volume of shows with which FX’s competitors flood the [...]

  • Longtime TV Editor Recalls Working for

    How a Bad Director Can Spoil the Show (Guest Column)

    I have been blessed with editing some of TV’s greatest shows, working with some of the industry’s greatest minds. “The Wonder Years,” “Arrested Development,” “The Office,” “Scrubs,” “Pushing Daisies” and, most recently, “A Series of Unfortunate Events.” I have earned an Emmy, ACE Eddie Awards, and many nominations. But whatever kudos I’ve received, over my [...]

  • Stock market Stock buyback

    Stock Buybacks Leave Firms Without Funds to Invest in Future (Column)

    Corporate giants on the S&P 500 have spent more than $720 billion during the past year on stock buybacks. Media and entertainment firms account for only a fraction of that spending, but even $1 million spent on share repurchases seems a foolhardy expenditure at this transformational moment for the industry. The record level of spending [...]

  • Hollywood Has Come Far With Diversity

    An Insider's Look at Hollywood's Diversity Efforts and How Far It Still Needs to Go

    I am a white man working in Hollywood. I grew up in Beverlywood, an all-white, predominantly Jewish, Los Angeles neighborhood sandwiched between 20th Century Fox Studios and MGM, where my elementary school had only one black student. I am compelled to write about diversity in Hollywood because “diversity” — in front of and behind the camera [...]

  • Venice Film Festival A Star is

    How Venice, Toronto and Telluride Festivals Stole Cannes' Luster (Column)

    In all the years I’ve been attending film festivals, I have never seen a lineup that looked as good on paper as Venice’s did this fall, boasting new films by Alfonso Cuarón (“Roma”), Damien Chazelle (“First Man”), Paul Greengrass (“22 July”), Mike Leigh (“Peterloo”) and the Coen brothers (“The Ballad of Buster Scruggs”) in competition, [...]

  • Black Women in Medicine BTS

    Hollywood Needs to Include People With Disabilities on Both Sides of the Camera (Guest Column)

    In five years, nothing has changed. Despite open calls for greater diversity and inclusion, recent research shows that there was little change in the number of characters with disabilities in popular films in 2017. A study conducted by the Annenberg Inclusion Initiative of the University of Southern California’s Annenberg School for Communication and Journalism found that [...]

More From Our Brands

Access exclusive content